BAJAJ BROKING
Bharat Electronics Ltd. (BEL) secured orders worth ₹973 crore, including metro rail systems, radars, and sonar. BEL has achieved 40% of its ₹25,000 crore FY25 target. Shares rose by 1.1%, closing at ₹294.1.
Bharat Electronics Ltd. (BEL), a Navratna PSU, announced new orders worth ₹973 crore in its latest exchange filing. These orders include platform screen doors for metro rail, radars, communication equipment, upgraded sonar systems, and satellite communication terminals. With this achievement, BEL’s order inflows for FY25 now total ₹9,801 crore, reaching 40% of its projected ₹25,000 crore order guidance for the financial year.
Also read: Adani Defence Acquires 85.8% Stake in Air Works for ₹400 Crore
Recent Order Value: ₹973 crore.
Total Orders FY25: ₹9,801 crore.
Target Order Guidance FY25: ₹25,000 crore.
Orders Include: Metro systems, radars, sonar, and satellite communication terminals.
Share Performance: BEL share price increased by 1.1%, closing at ₹294.1.
Also read: TVS Motor Acquires Majority Stake in DriveX with 87.38% Holding
The ₹973 crore order win highlights BEL’s diverse portfolio, catering to metro rail infrastructure, defence applications, and advanced communication systems. A breakdown of the latest orders is as follows:
Order Category | Details |
Metro Rail Systems | Platform screen doors |
Defence Applications | Radars, sonar, and jammers |
Communication Equipment | Upgraded satcom terminals |
Support Services | Test stations and spares |
BEL’s total order inflow for FY25 stands at ₹9,801 crore, reflecting 40% of its full-year target of ₹25,000 crore. The company aims to secure significant additional orders in the second half of FY25 to meet its guidance.
Shares of BEL gained 1.1% on the BSE, closing at ₹294.1. The BEL share price has shown a robust 59% growth in 2024, underscoring strong investor confidence in the company’s prospects.
BEL’s latest order win reinforces its market leadership in defence and infrastructure sectors. With substantial progress towards its FY25 guidance, BEL remains focused on expanding its order book and driving growth in strategic projects.
Also read: US FDA Restricts Imports of Viatris Drugs Manufactured at Indian Facility
Do you have a trading account app or demat account app?
You can open an account with Bajaj Broking in minutes.
Download the Bajaj Broking app now from Play Store or App Store.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading